PMID- 11730854 OWN - NLM STAT- MEDLINE DCOM- 20020201 LR - 20210103 IS - 0022-1759 (Print) IS - 0022-1759 (Linking) VI - 259 IP - 1-2 DP - 2002 Jan 1 TI - mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). PG - 191-203 AB - Dendritic cells (DCs) are recognised as the most potent antigen-presenting cells for induction of cellular immune responses, and vaccination with DCs pulsed with antigens has emerged as a promising strategy for generating protective immunity in mammals. We have developed a transfection method that uses in vitro synthesised mRNA and square-wave electroporation for transient expression in DCs and other cell types. The method is highly efficient and produces almost complete transfection of cells in culture. When using mRNA encoding the enhanced green fluorescence protein (EGFP), highest expression in DCs occurred on the second day after transfection and produced a 76-fold increase in mean fluorescence above background. High levels of expression were maintained for at least 5 days post-transfection. In comparison, square-wave electroporation of DCs with EGFP plasmid DNA yielded 15% transfected cells and a 28-fold increase of mean fluorescence. DCs transfected with mRNA encoding the telomerase catalytic subunit (hTERT) acquired strong telomerase activity and were capable of eliciting a hTERT-specific cytotoxic T lymphocyte (CTL) response in vitro. FAU - Saeboe-Larssen, Stein AU - Saeboe-Larssen S AD - Section for Immunotherapy, Department of Immunology, The Norwegian Radium Hospital, Cancer Research Institute, University of Oslo, N-0310 Montebello, Oslo, Norway. stein.saboe-larssen@samfunnsmed.uio.no FAU - Fossberg, Ellen AU - Fossberg E FAU - Gaudernack, Gustav AU - Gaudernack G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - J Immunol Methods JT - Journal of immunological methods JID - 1305440 RN - 0 (DNA-Binding Proteins) RN - 0 (RNA, Messenger) RN - EC 2.7.7.49 (Telomerase) SB - IM MH - Antigen Presentation/*genetics/*immunology MH - Catalytic Domain/genetics/immunology MH - Cells, Cultured MH - Cytotoxicity, Immunologic MH - DNA-Binding Proteins MH - Dendritic Cells/*immunology MH - Electroporation MH - Humans MH - RNA, Messenger/genetics/immunology MH - T-Lymphocytes, Cytotoxic/*immunology MH - Telomerase/*genetics/*immunology MH - Transfection/*methods EDAT- 2001/12/04 10:00 MHDA- 2002/02/02 10:01 CRDT- 2001/12/04 10:00 PHST- 2001/12/04 10:00 [pubmed] PHST- 2002/02/02 10:01 [medline] PHST- 2001/12/04 10:00 [entrez] AID - S0022175901005063 [pii] AID - 10.1016/s0022-1759(01)00506-3 [doi] PST - ppublish SO - J Immunol Methods. 2002 Jan 1;259(1-2):191-203. doi: 10.1016/s0022-1759(01)00506-3.